Guangzhou Wondfo Biotech Co.,Ltd (300482.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap9.57B
Enterprise Value9.12B
P/E Ratio-62.47
PEG Ratio0.7
Price/Sales Ratio4.17
Price/Book Ratio1.44
Enterprise/Revenue4.36
Enterprise/EBITDA161.85

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.07
Operating Margin-0.1
AD

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.02

Income Statement

Revenue2.09B
Revenue/Share4.03
Gross Profit1.19B
EBITDA179.91M
Net Income-63.02M
Diluted EPS-0.13

Balance Sheet

Total Cash2.62B
Total Cash/Share5.61
Total Debt645.61M
Total Debt/Equity0.12
Current Ratio3.32
Book Value Per Share11.81

Price History

52-Week Change-21.9
52-Week High26.29
52-Week Low15.4
Moving Average 50 Days16.71
Moving Average 200 Days18.52

Statistics

Average Volume6.71M
Shares Outstanding468.09M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.22
Trailing Annual Dividend Yield1.31
Payout Ratio-0.75
Last Split Factor13:10
Last Split DateMay 26, 2021
AD